| __timestamp | Eli Lilly and Company | PTC Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 6620800000 | 44820000 |
| Thursday, January 1, 2015 | 6533000000 | 82080000 |
| Friday, January 1, 2016 | 6452000000 | 97130000 |
| Sunday, January 1, 2017 | 6588100000 | 121271000 |
| Monday, January 1, 2018 | 5975100000 | 153548000 |
| Tuesday, January 1, 2019 | 6213800000 | 202541000 |
| Wednesday, January 1, 2020 | 6121200000 | 245164000 |
| Friday, January 1, 2021 | 6431600000 | 285773000 |
| Saturday, January 1, 2022 | 6440400000 | 325998000 |
| Sunday, January 1, 2023 | 6941200000 | 332540000 |
| Monday, January 1, 2024 | 8593800000 |
Infusing magic into the data realm
In the ever-evolving pharmaceutical landscape, operational efficiency is paramount. Over the past decade, Eli Lilly and Company and PTC Therapeutics, Inc. have showcased contrasting strategies in managing their Selling, General, and Administrative (SG&A) expenses. Eli Lilly, a stalwart in the industry, consistently allocated a significant portion of its budget to SG&A, peaking at approximately $6.9 billion in 2023. This represents a steady increase of around 5% from 2014. In contrast, PTC Therapeutics, a burgeoning biotech firm, saw its SG&A expenses skyrocket by over 640% during the same period, reaching $332 million in 2023. This dramatic rise underscores PTC's aggressive expansion and investment in operational infrastructure. As these companies navigate the complexities of the pharmaceutical sector, their SG&A strategies offer a window into their broader business philosophies and growth trajectories.
Eli Lilly and Company or Insmed Incorporated: Who Manages SG&A Costs Better?
SG&A Efficiency Analysis: Comparing Eli Lilly and Company and Sarepta Therapeutics, Inc.
Breaking Down SG&A Expenses: Eli Lilly and Company vs CymaBay Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Eli Lilly and Company and ACADIA Pharmaceuticals Inc.
Eli Lilly and Company vs Taro Pharmaceutical Industries Ltd.: SG&A Expense Trends
Comparing SG&A Expenses: Incyte Corporation vs PTC Therapeutics, Inc. Trends and Insights
Operational Costs Compared: SG&A Analysis of Grifols, S.A. and PTC Therapeutics, Inc.
Selling, General, and Administrative Costs: Cytokinetics, Incorporated vs PTC Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Opthea Limited and PTC Therapeutics, Inc.
PTC Therapeutics, Inc. vs Perrigo Company plc: SG&A Expense Trends
Operational Costs Compared: SG&A Analysis of PTC Therapeutics, Inc. and Bausch Health Companies Inc.
Who Optimizes SG&A Costs Better? PTC Therapeutics, Inc. or MannKind Corporation